Sourav Sarkar Email

Senior Scientist . Cygnal Therapeutics

Current Roles

Employees:
16
Revenue:
$1.2M
About
Founded in 2017 by Flagship Pioneering, Cygnal Therapeutics is the first company to build a platform to develop drugs in the field of exoneural biology. Exoneural biology is broadly implicated in human health and disease. Fueled by our dynamic Exoneural Medicine Platformᅢᄁ¬ダᅡᄁ, we are creating new medicines across multiple therapeutic areas, starting with cancer and inflammatory diseases.
Cygnal Therapeutics Address
325 Vassar St
Cambridge, MA
United States
Cygnal Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.